TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | -1 | 8 | 2 | -14 | -39 | -8 |
| P | %wins | 0 | 50 | 50 | 50 | 50 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/12 15:29 | 3/2/12 | HZNP | Horizon Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund VI LP | MA | T | P.d | 3,000 | 3.62 | 0 | 828 | 29 | 3,688 | I | -58 | -33 | -15 | -15 | -2 | -1 | -2 | 6 | 26 | 10 | 31 | -34 | |||
8/4/11 17:12 | 8/2/11 | HZNP | Horizon Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund VI LP | MA | T | P.d | 3,328 | 9.00 | 2 | 370 | 7 | 5,393 | I | 0 | -1 | -7 | -10 | -7 | -59 | -44 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |